Kim Mouridsen1, Dominique Jennings1,
Elisa Gelasca1,
1Athinoula A. Martinos Center for
Biomedical Imaging, Department of Radiology, Massachusetts General Hospital,
Charlestown, MA, United States; 2Stephen E. & Catherine Pappas
Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA, United
States
Dynamic
contrast enhanced MRI (DCE-MRI) holds potential for characterizing key
physiological markers of tumor vascularity such as blood
brain-barrier-permeability. Reproducibility of pharmacokinetic parameters in
multicenter settings is contingent on reliable characterization of the
vascular input function (VIF). This is compromised by signal attenuating T2*
effects at high concentrations and insensitivity of typical T1-weighted
sequences at peak bolus passage, as well as non-reproducible manual
identification of VIFs. We demonstrate that a completely automatic VIF
identification procedure combined with T2* based estimation of peak
concentration yields VIF reproducibility comparable to expert manual
selection in two pre-treatment baseline scans of 10 glioblastoma patients.